Newborn screening for congenital adrenal hyperplasia in Srinagarind Hospital, Khon Kaen University, Thailand

1. Pang S, Shook MK. Current status of neonatal screening for congenital adrenal hyperplasia. Curr Opin Pediatr. 1997; 9:419-23.10.1097/00008480-199708000-00018Open DOISearch in Google Scholar

2. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000; 21:245-91.Search in Google Scholar

3. Pang S, Hotchkiss J, Drash AL, Levine LS, New MI. Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1977; 45:1003-8.10.1210/jcem-45-5-1003Open DOISearch in Google Scholar

4. Pang S, Murphey W, Levine LS, Spence DA, Leon A, LaFranchi S, et al. A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab. 1982; 55:413-20.10.1210/jcem-55-3-413Open DOISearch in Google Scholar

5. Janejai N, Krasao P, Phansang J, Pankarnjanato R, Charoensiriwatana W. Congenital adrenal hyperplasia: should nationwide screening be implemented in Thailand? Southeast Asian J Trop Med Public Health. 2003; 34 Suppl 3:170-3.Search in Google Scholar

6. Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weightadjusted criteria for 17-hydroxyprogesterone levels. J Pediatr. 1997; 130:128-33.10.1016/S0022-3476(97)70321-4Open DOISearch in Google Scholar

7. Hingre RV, Gross SJ, Hingre KS, Mayes DM, Richman RA. Adrenal steroidogenesis in very low birth weight preterm infants. J Clin Endocrinol Metab. 1994; 78: 266-70.Search in Google Scholar

8. van der Kamp HJ, Oudshoorn CG, Elvers BH, van Baarle M, Otten BJ, Wit JM, et al. Cutoff levels of 17- alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. J Clin Endocrinol Metab. 2005; 90:3904-7.10.1210/jc.2004-2136Open DOISearch in Google Scholar

9. Torresani T, Grüters A, Scherz R, Burckhardt JJ, Harras A, Zachmanna M. Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut-off level of 17á- hydroxyprogesterone to gestational age. Screening. 1994; 3:77-84.10.1016/0925-6164(94)90003-5Open DOISearch in Google Scholar

10. Olgemoller B, Roscher AA, Liebl B, Fingerhut R. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value. J Clin Endocrinol Metab. 2003; 88: 5790-4.10.1210/jc.2002-02173214671170Open DOISearch in Google Scholar

11. Ersch J, Beinder E, Stallmach T, Bucher HU, Torresani T. 17-Hydroxyprogesterone in premature infants as a marker of intrauterine stress. J Perinat Med. 2008; 36: 157-60.10.1515/JPM.2008.01318211251Search in Google Scholar

12. Murphy JF, Joyce BG, Dyas J, Hughes IA. Plasma 17-hydroxyprogesterone concentrations in ill newborn infants. Arch Dis Child. 1983; 58:532-4.10.1136/adc.58.7.53216282036870334Open DOISearch in Google Scholar

13. Nordenstrom A, Wedell A, Hagenfeldt L, Marcus C, Larsson A. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics. 2001; 108:E68. 10.1542/peds.108.4.e6811581476Search in Google Scholar